Clinical Trials Browser

Phase 1/2 × Neoplasms, Basal Cell × Erlotinib Hydrochloride × Clear all

NCT06483555 2025-04-16

PANGEA

Phase 1/2 Recruiting

DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell